Publication | Closed Access
Bezafibrate, a peroxisome proliferator–activated receptor α agonist, decreases circulating CD14+CD16+ monocytes in patients with type 2 diabetes
19
Citations
17
References
2014
Year
InflammationMetabolic SyndromeReceptor α AgonistDiabetes ManagementDiabetesImmunologyImmune RegulationType 2Cd14+cd16+ MonocytesDiabetes ComplicationsDiabetes MellitusMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1